
Feromics uses AI-powered single-cell analysis to tailor immunotherapies. Its Intelligent Design platform integrates single-cell analytics, AI insights, and proprietary disease-specific datasets to reveal immune mechanisms. The company operates as a biotechnology platform serving pharma and research organizations with precision medicine tools. It aims to translate immune decoding into patient-centric treatments and scale targeted therapies across immune-mediated diseases.

Feromics uses AI-powered single-cell analysis to tailor immunotherapies. Its Intelligent Design platform integrates single-cell analytics, AI insights, and proprietary disease-specific datasets to reveal immune mechanisms. The company operates as a biotechnology platform serving pharma and research organizations with precision medicine tools. It aims to translate immune decoding into patient-centric treatments and scale targeted therapies across immune-mediated diseases.